Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -21.898% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CC(NC(=O)C(=O)N1CCCCC1)C(c1cccs1)N1CCN(c2ccc(F)cc2)CC1
b) Cc1cc(SCC(=O)NCC2CCCO2)nc2ccccc12
Answer: a. CC(NC(=O)C(=O)N1CCCCC1)C(c1cccs1)N1CCN(c2ccc(F)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(NC(=O)C(=O)N1CCCCC1)C(c1cccs1)N1CCN(c2ccc(F)cc2)CC1
CC(NC(=O)C(=O)N1CCCCC1)C(c1cccs1)N1CCN(c2ccc(F)cc2)CC1
N-[1-[4-(4-fluorophenyl)piperazin-1-yl]-1-thiophen-2-ylpropan-2-yl]-2-oxo-2-piperidin-1-ylacetamide